Skip to search formSkip to main contentSkip to account menu

BCMA-specific CAR-expressing T Lymphocytes

Known as: Anti-BCMA CAR T Cells, Anti-BCMA-CAR-transduced T Cells 
A preparation of autologous peripheral blood T-lymphocytes (PBTL) that have been genetically modified to express a chimeric antigen receptor (CAR… 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

BB2121

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Auch beim multiplen Myelom eine Option?
Schreitet beim multiplem Myelom trotz mehrerer Therapieversuche mit Proteasominhibitoren, immunmodulierenden Substanzen und… 
2020
2020
Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma
2017
2017
Strategies Through Clinical Simulation to Support Nursing Students and Their Learning of Barcode Medication Administration (BCMA) and Electronic Medication Administration Record (eMAR) Technologies
2016
2016
New Insights into the Mechanism of Action (MoA) of First-in-Class IgG-Based Bcma T-Cell Bispecific Antibody (TCB) for the Treatment of Multiple Myeloma (MM)
Novel agents have improved outcomes in MM, but prognosis after patients relapse remains poor and new drugs with novel MoA are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)